SCHEMBL26056548

SCHEMBL26056548

c1ccc(-c2ccc(N(c3ccc(-c4ccc5ccc6c7ccccc7ccc6c5c4)cc3)c3cccc4c3oc3ccccc34)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.36
▸ PLA2G4A P47712 3/20 0.36
▸ ALOX5 P09917 2/20 0.36
▸ HPRT1 P00492 3/20 0.35
▸ PLA2G10 O15496 1/20 0.35
▸ CYP1A1 P04798 5/20 0.34
▸ CYP1A2 P05177 5/20 0.34
▸ CYP1B1 Q16678 4/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ TSHR P16473 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ ABCG2 Q9UNQ0 2/20 0.34
▸ PDE5A O76074 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26056663 0.98 ALOX5 (0.36) PLA2G2APLA2G4AALOX5HPRT1PLA2G10
SCHEMBL27048286 0.95 ALOX5 (0.36) PLA2G2APLA2G4AALOX5HPRT1PLA2G10
SCHEMBL26056435 0.95 ALOX5 (0.36) PLA2G2APLA2G4AALOX5HPRT1CYP1A1
SCHEMBL22107892 0.95 ALOX5 (0.38) PLA2G2APLA2G4AALOX5HPRT1PLA2G10
SCHEMBL25463896 0.95 ALOX5 (0.39) PLA2G2APLA2G4AALOX5HPRT1PLA2G10
SCHEMBL23258924 0.94 ALOX5 (0.37) PLA2G2APLA2G4AALOX5HPRT1PLA2G10
SCHEMBL26057208 0.93 ALOX5 (0.36) PLA2G2APLA2G4AALOX5HPRT1CYP1A1
SCHEMBL26056955 0.93 ALOX5 (0.36) PLA2G2APLA2G4AALOX5HPRT1CYP1A1
SCHEMBL23471784 0.93 ALOX5 (0.36) PLA2G2APLA2G4AALOX5HPRT1PLA2G10
SCHEMBL24887016 0.93 PLA2G2A (0.38) PLA2G2APLA2G4AALOX5PLA2G10CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025840-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2024-01-25 — — US disclosed
US-20240025840-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2024-01-25 — — US disclosed
EP-4235829-A1 ORGANIC LIGHT-EMITTING DEVICE Lg Chem, Ltd. (KR) 2023-08-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025840-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, TMEM109 PLA2G2A 3986/4885PLA2G4A 3985/4885ALOX5 736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback